Focus: QT Imaging develops quantitative transmission ultrasound technology for medical imaging and equipment applications. The company operates as a specialized biotech focused on imaging modalities rather than traditional drug development.
Profile data last refreshed 4h ago · AI intelligence enriched 1mo ago
Growing — net +13 jobs in 30d
13 jobs added vs 0 removed. Steady team buildout.
QT Imaging is an early-stage imaging technology play with potential upside for AI/ML specialists, but extreme opacity on financials, stage, and validation creates significant career risk—suitable only for risk-tolerant professionals seeking founder equity upside.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for QT Imaging
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from QT Imaging's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo